Cargando…

Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine

BACKGROUND: Stomach adenocarcinoma (STAD) is one of the primary contributors to deaths that are due to cancer globally. At the moment, STAD does not have any universally acknowledged biological markers, and its predictive, preventive, and personalized medicine (PPPM) remains sufficient. Oxidative st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Ying, Yuan, Qihang, Ren, Jie, Li, Hanshuo, Guo, Hui, Guan, Hewen, Jiang, Xueyan, Qi, Bing, Li, Rongkuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969989/ https://www.ncbi.nlm.nih.gov/pubmed/36860371 http://dx.doi.org/10.3389/fendo.2023.1090906

Ejemplares similares

Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes
por: Cui, Yougang, et al.
Publicado: (2023)

Identifying Pupylation Proteins and Sites by Incorporating Multiple Methods
por: Qiu, Wang-Ren, et al.
Publicado: (2022)

Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2022)

WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma
por: Yuan, Qihang, et al.
Publicado: (2021)

Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction
por: Zhang, Yong, et al.
Publicado: (2023)

Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer
por: Chen, Xu, et al.
Publicado: (2023)

Editorial: Personalized Medicine in Cancer Research
por: Werner, Haim, et al.
Publicado: (2018)

Feasibility analysis of incorporating infertility into medical insurance in China
por: Wang, Lin, et al.
Publicado: (2022)

Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling
por: Liu, Chunhua, et al.
Publicado: (2022)

Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
por: Guo, Yuna, et al.
Publicado: (2022)

Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease
por: Zhong, Fang, et al.
Publicado: (2021)

The Value of HPA Axis Hormones as Biomarkers for Screening and Early Diagnosis of Postpartum Depression: Updated Information About Methodology
por: Chai, Yujuan, et al.
Publicado: (2022)

Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach
por: Reglodi, Dora, et al.
Publicado: (2018)

From an Empty Stomach to Anxiolysis: Molecular and Behavioral Assessment of Sex Differences in the Ghrelin Axis of Rats
por: Börchers, Stina, et al.
Publicado: (2022)

High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women
por: Li, Qihang, et al.
Publicado: (2021)

Corrigendum: High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women
por: Li, Qihang, et al.
Publicado: (2021)

Zebrafish for Personalized Regenerative Medicine; A More Predictive Humanized Model of Endocrine Disease
por: Arjmand, Babak, et al.
Publicado: (2020)

Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience
por: Kölker, Stefan, et al.
Publicado: (2022)

Mouse Spexin: (III) Differential Regulation by Glucose and Insulin in Glandular Stomach and Functional Implication in Feeding Control
por: Chen, Yuan, et al.
Publicado: (2021)

Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine
por: Matrone, Antonio, et al.
Publicado: (2020)

The Identification of Alternative Polyadenylation in Stomach Adenocarcinomas Using the Genotype-Tissue Expression Project and the Cancer Genome Atlas– Stomach Adenocarcinoma Profiles
por: Li, Jian, et al.
Publicado: (2021)

Editorial: New molecular targets involved in lung adenocarcinoma
por: Zhan, Xianquan, et al.
Publicado: (2023)

Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
por: Zhou, Daxiang, et al.
Publicado: (2023)

Cortisol dysregulation in anxiety infertile women and the influence on IVF treatment outcome
por: Chai, Yujuan, et al.
Publicado: (2023)

Classification of diabetic retinopathy: Past, present and future
por: Yang, Zhengwei, et al.
Publicado: (2022)

Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma
por: Li, Fangfang, et al.
Publicado: (2022)

Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach
por: Albini, Adriana, et al.
Publicado: (2018)

Hepatoid adenocarcinoma of the stomach with neuroendocrine differentiation: A case report and review of literature
por: Fei, He, et al.
Publicado: (2023)

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
por: Luo, Wen-Zhao, et al.
Publicado: (2023)

Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer
por: Li, Xingchen, et al.
Publicado: (2021)

Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis
por: Liang, Xueyan, et al.
Publicado: (2023)

Hepatoid adenocarcinoma of the stomach: CT findings
por: Yang, Qian, et al.
Publicado: (2023)

Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer
por: Zhang, Biao, et al.
Publicado: (2023)

Deep neural network for discovering metabolism-related biomarkers for lung adenocarcinoma
por: Fu, Lei, et al.
Publicado: (2023)

Anatomical classification of the shape and topography of the stomach
por: Burdan, Franciszek, et al.
Publicado: (2011)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

Statin Use and Benefits of Thyroid Function: A Retrospective Cohort Study
por: Wang, Yupeng, et al.
Publicado: (2021)

The Relationship Between Obesity and Depression Is Partly Dependent on Metabolic Health Status: A Nationwide Inpatient Sample Database Study
por: Wang, Zhixiang, et al.
Publicado: (2022)

Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets
por: Ren, Na, et al.
Publicado: (2020)

Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus
por: Zeng, Yongji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4cu2t0nm269ti8hme86fubvq4t